Pablo Taboada
Overview
Explore the profile of Pablo Taboada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
114
Citations
838
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Costa R, Dominguez-Arca V, Velasco B, Reis R, Rodriguez-Cabello J, Pashkuleva I, et al.
ACS Appl Mater Interfaces
. 2024 Nov;
16(48):66327-66340.
PMID: 39561189
Current models for elastin-like recombinamer (ELR) design struggle to predict the effects of nonprotein fused materials on polypeptide conformation and temperature-responsive properties. To address this shortage, we investigated the novel...
2.
Sanchez-Arribas N, Velasco Rodriguez B, Aicart E, Guerrero-Martinez A, Junquera E, Taboada P
J Colloid Interface Sci
. 2024 Nov;
679(Pt B):975-987.
PMID: 39488022
The therapeutic messenger RNA strategies, such as those using small interfering RNAs, take several advantages (versatility, efficiency and selectivity) over plasmid DNA-based strategies. However, the challenge remains to find nanovectors...
3.
Ferreira J, Dominguez-Arca V, Carneiro J, Prieto G, Taboada P, Moreira de Campos J
ACS Omega
. 2024 Jun;
9(22):23364-23376.
PMID: 38854527
Although the (CNT) is the most consensual theory to explain protein nucleation mechanisms, experimental observations during the shear-induced assays suggest that the CNT does not always describe the insulin nucleation...
4.
Arellano L, Martinez R, Pardo A, Diez I, Velasco B, Moreda-Pineiro A, et al.
J Colloid Interface Sci
. 2024 May;
668:575-586.
PMID: 38691966
Lanthanide-doped up-converting nanoparticles (UCNPs) have emerged as promising biomedical tools in recent years. Most research efforts were devoted to the synthesis of inorganic cores with the optimal physicochemical properties. However,...
5.
Mendez-Pfeiffer P, Ballesteros-Monrreal M, Juarez J, Gastelum-Cabrera M, Martinez-Flores P, Taboada P, et al.
ACS Infect Dis
. 2024 Jan;
10(4):1126-1136.
PMID: 38287229
Urinary tract infections are commonly caused by uropathogenic (UPEC), which usually presents multiple virulence and resistance mechanisms, making it difficult to treat. It has been demonstrated that silver and polymeric...
6.
Beltran O, Luna M, Gastelum M, Costa-Santos A, Cambon A, Taboada P, et al.
Pharmaceutics
. 2023 Nov;
15(11).
PMID: 38004550
Gold nanorods (AuNRs) have attracted attention in the field of biomedicine, particularly for their potential as photothermal agents capable of killing tumor cells by photothermic ablation. In this study, the...
7.
Vivanco P, Taboada P, Coelho A
Nutrients
. 2023 Oct;
15(19).
PMID: 37836558
Scientific evidence increasingly supports the strong link between diet and health, acknowledging that a well-balanced diet plays a crucial role in preventing chronic diseases such as obesity, diabetes, cardiovascular issues,...
8.
Villar-Alvarez E, Golan-Cancela I, Pardo A, Velasco B, Fernandez-Vega J, Cambon A, et al.
Small
. 2023 Aug;
19(50):e2303934.
PMID: 37632323
Treatment failure in breast cancers overexpressing human epidermal growth factor receptor 2 (HER2) is associated mainly to the upregulation of human epidermal growth factor receptor 3 (HER3) oncoprotein linked to...
9.
Ibarra J, Encinas-Basurto D, Almada M, Juarez J, Valdez M, Barbosa S, et al.
Micromachines (Basel)
. 2023 Jul;
14(7).
PMID: 37512701
Conventional cancer therapies suffer from nonspecificity, drug resistance, and a poor bioavailability, which trigger severe side effects. To overcome these disadvantages, in this study, we designed and evaluated the in...
10.
Oceguera-Basurto P, Figueroa-Ochoa E, Anguiano-Sevilla L, Sanchez-Ramirez D, Quintero-Ramos A, Del Toro-Arreola A, et al.
Int J Pharm
. 2023 Jun;
642:123175.
PMID: 37369286
Breast cancer (BC) has surpassed lung cancer as the most diagnosed cancer and, in terms of mortality, is the fifth leading cause with 684,996 new deaths (6.7% of all cancer-related...